Concepedia

Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators

Sanam Dolati, Majid Ahmadi, Leili Aghebti-Maleki, Abbas Nikmaram, Faroogh Marofi, Reza Rikhtegar, Hormoz Ayromlou, Mehdi Yousefi

Pharmacological Reports · 2018 · 96 citations · 24 references

DOI

Concepts

References

24

Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation

Arian Laurence, Cristina M. Tato, Todd S. Davidson et al. · Immunity · 2007 · 1.5K citations · Full text

, , +15

Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls

Andreas Keller, Petra Leidinger, Julia Lange et al. · PLoS ONE · 2009 · 365 citations · Full text

, , +16

Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors

Míriam Mecha, Ana Feliú, Paula M. Iñigo et al. · Neurobiology of Disease · 2013 · 284 citations · Full text

, , +17

Multiple sclerosis prevalence in the United States commercially insured population

Piyameth Dilokthornsakul, Robert J. Valuck, Kavita Nair et al. · Neurology · 2016 · 278 citations · Full text

, , +12

The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial.

Hamid Reza Rahimi, Amir Hooshang Mohammadpour, Mostafa Dastani et al. · PubMed · 2016 · 201 citations · Full text

, , +17